Statistics from Altmetric.com
In a short-term (8 weeks) randomised, clinical trial, a 2 ml local injection of autologous blood was more effective in reducing pain and improving function than the corticosteroid injection from chronic lateral epicondylopathy (‘tennis’ elbow)
A number of treatment modalities have been suggested for the management of chronic lateral epicondylopathy (‘tennis’ elbow).
Does a local autologous blood injection improve pain and function more than a local corticosteroid injection in patients with lateral elbow tendinopathy?
Subjects 60 patients with lateral epicondylopathy (‘tennis’ elbow) (27–64 years).
Experimental procedure All the subjects were assessed (pain (VAS-severity in last 24 h; pain and strength in maximum grip; pressure pain threshold), disability (arm, shoulder, and hand quick questionnaire – Quick DASH scores; modified Nirschl scores)) and then randomised to either injection with either methylprednisolone (CORT group=30; male=4, 20 mg and 1 ml lidocaine) or autologous blood group (AB group=30; male=7; 2 ml blood and 1 ml lidocaine). Re-assessment were conducted at 4 and 8 weeks postinjection.
Measures of outcome Pain, DASH score, Nirschl score, muscle strength and pressure pain threshold.
4 weeks There was a significantly greater improvement in pain (p=0.001), pain in grip (p=0.002), pressure pain threshold (p=0.031), and Quick DASH questionnaire score (p=0.004) in the AB compared with the CORT group.
8 weeks There was a significantly greater improvement of outcome measures in the AB compared with the CRT group (all p values <0.001).
In a short-term (8 weeks) randomised, …
Competing interests Commissioned; internally peer reviewed.
Provenance and peer review Commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.